http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2706270-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_545d3d0f10a10f18a29b2e6fe67f3ce8 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
filingDate | 2010-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8dcacad0a71e8588dd74b0cc2054e52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_538391f01896250b9e47efd82c509c48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c96c3b1da0a9ec2d82939147c9e4381 |
publicationDate | 2011-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2706270-A1 |
titleOfInvention | Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation |
abstract | A multi phase soft gelatin dosage form comprising at least one preformed solid dosage form comprising a statin compound and at least one liquid fill phase comprising Omega-3 fatty acids. The multi phase soft gelatin dosage forms of the present invention are especially useful to combine at least one solid dosage form and at least one liquid phase for single ingestion. The solid phase, liquid phase or coatings may further comprise active pharmaceutical ingredients, nutraceuticals, nutritional supplements, or therapeutic substances, functional excipients or combinations thereof. |
priorityDate | 2010-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.